Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Newly Diagnosed Multiple Myeloma
Related studies linked through entity extraction aliases.
A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
- Status
- RECRUITING
- Phase
- PHASE3